BMC Medical Co. Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005WQ4
CNY
66.93
1.45 (2.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
264.38
278.55
265.29
241.40
219.92
190.08
192.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
264.38
278.55
265.29
241.40
219.92
190.08
192.09
Raw Material Cost
124.81
129.20
136.65
145.17
112.54
95.18
95.99
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.12
1.69
1.74
0.53
1.73
0.29
0.29
Selling and Distribution Expenses
55.19
55.51
39.05
52.63
43.63
43.65
31.11
Other Expenses
2.93
2.78
2.42
3.18
2.91
3.10
2.31
Total Expenditure (Excl Depreciation)
210.40
214.22
201.64
230.12
187.01
170.08
150.46
Operating Profit (PBDIT) excl Other Income
54
64.3
63.6
11.299999999999999
32.9
20
41.6
Other Income
9.49
19.70
22.63
29.63
14.08
29.31
15.04
Operating Profit (PBDIT)
59.65
81.50
88.68
32.59
48.80
53.84
62.68
Interest
1.12
1.69
1.74
0.53
1.73
0.29
0.29
Exceptional Items
0.85
-0.57
2.64
8.48
1.84
0.00
0.12
Gross Profit (PBDT)
139.57
149.35
128.64
96.23
107.37
94.90
96.10
Depreciation
0.00
7.03
7.03
6.79
6.79
6.63
6.63
Profit Before Tax
59.38
72.22
82.54
33.75
42.12
46.92
55.88
Tax
7.63
10.54
7.75
0.17
8.47
3.82
5.08
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
48.66
59.41
71.93
30.26
32.74
42.46
49.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
48.66
59.41
71.93
30.26
32.74
42.46
49.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.00
1.41
0.99
0.79
1.08
0.71
0.64
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.66
60.83
72.92
31.05
33.82
43.17
50.55
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,980.29
2,926.27
2,898.40
2,828.26
2,798.17
2,796.14
2,829.19
Earnings per share (EPS)
0.55
0.67
0.81
0.34
0.37
0.47
0.56
Diluted Earnings per share
0.55
0.67
0.81
0.34
0.37
0.47
0.56
Operating Profit Margin (Excl OI)
18.97%
19.67%
22.25%
-1.59%
12.7%
9.42%
21.35%
Gross Profit Margin
22.46%
28.45%
33.76%
16.8%
22.24%
28.17%
32.54%
PAT Margin
18.41%
21.33%
27.11%
12.54%
14.89%
22.34%
25.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 20.24% vs 10.50% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 50.00% vs 22.91% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 44.67% vs 99.43% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -35.29% vs 466.67% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of BMC Medical Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
264.38
0
264.38
Other Operating Income
0.00
0.00
0.00
Total Operating income
264.38
0
264.38
Raw Material Cost
124.81
0
124.81
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.12
0
1.12
Selling and Distribution Expenses
55.19
0
55.19
Other Expenses
2.93
0.00
2.93
Total Expenditure (Excl Depreciation)
210.40
0
210.40
Operating Profit (PBDIT) excl Other Income
53.98
0.00
53.98
Other Income
9.49
0
9.49
Operating Profit (PBDIT)
59.65
0
59.65
Interest
1.12
0
1.12
Exceptional Items
0.85
0
0.85
Gross Profit (PBDT)
139.57
0
139.57
Depreciation
0.00
0
0.00
Profit Before Tax
59.38
0
59.38
Tax
7.63
0
7.63
Provisions and contingencies
0
0
0.00
Profit After Tax
48.66
0
48.66
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
48.66
0
48.66
Share in Profit of Associates
0
0
0.00
Minority Interest
2.00
0
2.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.66
0
50.66
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,980.29
0
2,980.29
Earnings per share (EPS)
0.55
0
0.55
Diluted Earnings per share
0.55
0
0.55
Operating Profit Margin (Excl OI)
18.97%
0%
0.00
18.97%
Gross Profit Margin
22.46%
0%
0.00
22.46%
PAT Margin
18.41%
0%
0.00
18.41%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 26.44 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -5.10% vs 5.01% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 20.24% vs 10.50% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.07 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -16.61% vs -16.60% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 50.00% vs 22.91% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.02 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -18.77% vs -6.36% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 44.67% vs 99.43% in Sep 2024

Quarterly - Interest
Interest 0.11 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -35.29% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -35.29% vs 466.67% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.97%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024